DiveRadGel Inc. is an early-stage life sciences company focused on pharmaceutical materials and drug-delivery technologies. It develops advanced excipients and formulation approaches intended to enable stable injectable dosage forms, improve solubility of challenging active ingredients, and support sustained-release profiles.
Positioned at the intersection of chemistry and biopharma, the company works with drug developers to translate enabling materials into clinical formulations, with applications spanning vaccines, biologics, and oncology therapies. DiveRadGel operates within the chemical industry’s specialty materials segment serving the development and manufacturing of injectable medicines.